Kilitch Drugs (India) Limited(IN:KILITCH)
₹200.85+3.60 (+1.83%)
IN:KILITCH
Kilitch Drugs (India) Limited financials statements
₹200.85
At close:+3.60 (+1.83%)
Want to see IN:KILITCH full AI Analyst Report?
Kilitch Drugs (India) Limited (KILITCH) Financial Statements
0 Followers
Kilitch Drugs (India) Limited Financial Overview
Kilitch Drugs (India) Limited's market cap is currently ₹6.90B. The company's EPS TTM is ₹6.98; its P/E ratio is 28.74; and it has a dividend yield of 0.40%. Kilitch Drugs (India) Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 2.35B | ₹ 1.98B | ₹ 1.54B | ₹ 1.40B | ₹ 1.14B |
| Gross Profit | ₹ 914.13M | ₹ 937.39M | ₹ 731.38M | ₹ 624.64M | ₹ 337.44M |
| Operating Income | ₹ 329.77M | ₹ 283.55M | ₹ 211.11M | ₹ 148.60M | ₹ 89.85M |
| EBITDA | ₹ 478.38M | ₹ 426.26M | ₹ 287.43M | ₹ 206.50M | ₹ 134.13M |
| Net Income | ₹ 301.66M | ₹ 267.01M | ₹ 146.01M | ₹ 104.48M | ₹ 73.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 687.39M | ₹ 593.98M | ₹ 690.19M | ₹ 591.77M | ₹ 572.43M |
| Total Assets | ₹ 4.58B | ₹ 3.13B | ₹ 2.40B | ₹ 2.20B | ₹ 2.10B |
| Total Debt | ₹ 887.09M | ₹ 494.24M | ₹ 316.46M | ₹ 221.94M | ₹ 204.32M |
| Net Debt | ₹ 719.33M | ₹ 396.24M | ₹ 127.36M | ₹ 23.48M | ₹ 104.22M |
| Total Liabilities | ₹ 1.81B | ₹ 1.12B | ₹ 643.88M | ₹ 689.41M | ₹ 695.55M |
| Stockholders' Equity | ₹ 2.80B | ₹ 2.02B | ₹ 1.76B | ₹ 1.52B | ₹ 1.39B |
| Cash Flow | |||||
| Free Cash Flow | ₹ -805.64M | ₹ -293.31M | ₹ -65.97M | ₹ -12.26M | ₹ -24.19M |
| Operating Cash Flow | ₹ 189.43M | ₹ 175.42M | ₹ -1.46M | ₹ 25.86M | ₹ 57.83M |
| Investing Cash Flow | ₹ -1.01B | ₹ -399.47M | ₹ -95.45M | ₹ 79.15M | ₹ -152.50M |
| Financing Cash Flow | ₹ 880.13M | ₹ 132.43M | ₹ 88.07M | ₹ -7.16M | ₹ 70.28M |
Currency in INR
